Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16740)	3/7/1998 7:56:00 PM
From: tuck	Read Replies (1) \| Respond to of 32384

Henry, Howdy to all on the thread; been laying off of late due to important versus trivial content. Seems better in recent days. I doubt HGF will get much press till year end, when preclinical assays and screening should be done. Meanwhile, an "estrogen serum" may be getting press very soon, as it may be the mystery compound from the Lilly deal. You know anything about such compounds, Henry, such as what they might be, and do, and what markets they'd address? Also, <<<OFF TOPIC>>>, do any threaders have a take on Aurora Biosciences? Management, partners, and technology all look good. Their market is large and they are making sales of their Ultra High Throughput Screening Systems. Jay Silverman of Robbie Stevens likes it. They're ahead of schedule on significant milestones. It's near its lows. I'm really attracted to it. Anyone hear negatives? Thanks, Tuck